Image

Glenmark Receives USFDA Approval for Fluticasone Nasal Spray

Glenmark Receives USFDA  Approval for Fluticasone Nasal Spray

Overview :

Glenmark Pharmaceuticals received USFDA approval for Fluticasone Propionate Nasal Spray USP, 0.05 mg per spray. The generic version of Flonase Nasal Spray targets the $295 million US market and strengthens Glenmark's respiratory portfolio.

What Is Fluticasone?
Fluticasone propionate is a corticosteroid used to reduce inflammation in the nasal passages. It is commonly used for allergic rhinitis and hay fever.

Generic Drug Approval
Generic drugs must be bioequivalent to the reference listed drug. This ensures they have the same safety and efficacy.

Glenmark's Respiratory Push
This approval follows Glenmark's earlier USFDA approval for Fluticasone Propionate Inhalation Aerosol (generic of Flovent HFA) on March 4, 2026.

Market Opportunity
The US market for Flonase is valued at approximately $295.2 million annually. This represents a significant revenue opportunity for Glenmark.

USFDA Significance
The USFDA is the US federal agency regulating medicines, food, and medical devices. Approval from the USFDA is considered a benchmark of quality.


Exam-Focused Points :

  • Company  Glenmark Pharmaceuticals Limited.

  • Product  Fluticasone Propionate Nasal Spray USP, 0.05 mg (50 mcg) per spray.

  • Reference Product  Flonase Nasal Spray (Haleon US Holdings LLC).

  • Approval Body  U.S. Food and Drug Administration (USFDA).

  • Drug Class  Corticosteroid.

  • Indication  Allergic rhinitis and related nasal symptoms.

  • Market Size  ~$295.2 million annual sales (12 months ending June 2026).


FAQs :

Q1: What is Fluticasone Propionate Nasal Spray?
A corticosteroid used to treat allergic rhinitis and nasal symptoms.

Q2: What is the significance of USFDA approval?
It allows Glenmark to market and sell the generic product in the United States.

Q3: What is the reference product?
Flonase Nasal Spray, marketed by Haleon US Holdings LLC.

Q4: What is bioequivalence?
It means the generic releases the active ingredient at a similar rate and extent as the reference drug.

Q5: What is the market size of Flonase?
Approximately $295.2 million in annual sales.

Month: 

Category: 

1